Patents Assigned to Princeton Drug Discovery, LLC
  • NOVEL INHIBITORS OF PROTEIN KINASES
    Publication number: 20170240545
    Abstract: Protein kinases are regulators of cellular signaling and their functional dysregulation is common in carcinogenesis and many other disease states or disorders. The present invention relates to novel chemical entities that have biological activity to modulate mammalian protein kinase enzymes. In particular, compounds of the invention display potent inhibition of breast tumor related kinase (BRK).
    Type: Application
    Filed: October 11, 2016
    Publication date: August 24, 2017
    Applicant: Princeton Drug Discovery, LLC
    Inventors: Kan He, Lining Cai